Holding(s) in Company

RNS Number : 7048E

Allergy Therapeutics PLC

11 April 2011

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Allergy Therapeutics PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

Highclere International Investors LLP

4. Full name of shareholder(s)  (if different from 3.):iv

The Highclere International Investors International Smaller Companies Fund The Highclere (Jersey) International Investors Smaller Companies Fund

5. Date of the transaction and date on which the threshold is crossed or reached: v

8th April, 2011

6. Date on which issuer notified:

11th April, 2011

7. Threshold(s) that is/are crossed or reached: vi, vii

Below 3%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary

9,372,940

9,372,940

8,670,540

8,670,540

0

2.79%

0

GB00B02LCQ05

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

N/A

N/A

N/A

N/A

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,670,540

2.79%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

N/A

Proxy Voting:

10. Name of the proxy holder:

Highclere International Investors LLP

11. Number of voting rights proxy holder will cease to hold:

Not Applicable

12. Date on which proxy holder will cease to hold voting rights:

Not Applicable

13. Additional information:

Highclere International Investors LLP ("Highclere LLP") acts as investment manager for the clients detailed in Question 4 above (the "Clients").  In acting for the Clients, Highclere LLP is given full discretion over their investments and are empowered to vote on their behalf.  However, Highclere LLP does not act as the Clients' custodian and therefore shares are not held in Highclere LLP's name but in the name of each Client's custodian bank.

14. Contact name:

Fergus Gilmour, Compliance Officer

15. Contact telephone number:

0207-258-9845

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name (including legal form of legal entities)

Highclere International Investors LLP

Contact address (registered office for legal entities)

2 Manchester Square London W1U 3PA

Phone number & email

0207-258-9845

Other useful information (at least legal representative for legal persons)

Attn: Fergus Gilmour, Compliance Officer

B: Identity of the notifier, if applicable

Full name

Highclere International Investors LLP

Contact address

2 Manchester Square London W1U 3PA

Phone number & email

0207-258-9845

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

Attn: Fergus Gilmour, Compliance Officer

C: Additional information

Highclere International Investors LLP ("Highclere LLP") acts as investment manager for the clients detailed in Question 4 above (the "Clients").  In acting for the Clients, Highclere LLP is given full discretion over their investments and are empowered to vote on their behalf.  However, Highclere LLP does not act as the Clients' custodian and therefore shares are not held in Highclere LLP's name but in the name of each Client's custodian bank.

 

END

 

 

HOLUAOVRARASAAR